REVIEW ABOUT DIABETIC NEPHROPATHY

Sabah Kamel Neama; Alaa Muhannad Talib; Athraa Kadhem Coz; Saja Hadi Abad

doi:10.61796/jmgcb.v1i7.782

Authors

Sabah Kamel Neama
Sabah@gmail.com
Alaa Muhannad Talib Al-Muthanna University - College of Science - Department of biology
Athraa Kadhem Coz University of Maysan - College of science - Department of biology
Saja Hadi Abad University of Thi-Qar - College of Science - Biological

Vol. 1 No. 7 (2024): Journal of Medical Genetics and Clinical Biology

Articles

July 26, 2024

Downloads

View Article

Abstract
How to Cite
Metrics
References
License

The main function of the kidney is to filter the blood, purify it, and then return it to the body. This is done by taking the blood into the kidney through the renal arteries. About one liter of blood is pumped to the kidney, and 1/5 of what the blood pumps is returned. After filtering, the blood returns back to the body through the renal veins diabetes, damage Figure 4: A scan showing the basic structure and function of the kidney: The kidney is associated with to the capillaries, and changes in the afferent and afferent arteries, which interfere with the blood pressure furnace of the capillary and renal blood vessels of many tissues, including the infiltration of the umbilical cord. This can be caused by kidney weakness or kidney failure, and if the kidneys do not function properly for a long period of, When the t and kidney capacity time, this may be the result of diarrhea, diabetes, or high blood pressure. Sometimes this is due to genetic factors, hormones in the body, which help in regulating blood pressure. And the regulates the consumption of calcium in the intestines, and maintains the amount production of red blood cells, in addition to romaine, which of water in the body, which is responsible for the body’s general functions, including blood sugar and controlling the amount of water and salt in the blood and some chemicals (F Walter, 2004). Diabetes Mellitus, Diabetes is known to be a disruption in the process of sugar metabolism, leading to high blood sugar levels (glycolysis).

. ACCORD Study Group; Cushman, W. C.; Evans, G. W.; Byington, R. P.; Goff Jr, D. C.; Grimm Jr, R. H.; Cutler, J. A.; Simons-Morton, D. G.; Basile, J. N.; Corson, M. A.; Probstfield, J. L.; Katz, L.; Peterson, K. A.; Friedewald, W. T.; Buse, J. B.; Bigger, J. T.; Gerstein, H. C.; Ismail-Beigi, F. (2010-04-29). "Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus". New England Journal of Medicine. 362 (17). 1575–1585.

. ADVANCE Collaborative Group; Patel, A.; MacMahon, S.; Chalmers, J.; Neal, B.; Billot, L.; Woodward, M.; Marre, M.; Cooper, M.; Glasziou, P.; Grobbee, D.; Hamet, P.; Harrap, S.; Heller, S.; Liu, L.; Mancia, G.; Mogensen, C. E.; Pan, C.; Poulter, N.; Rodgers, A.; Williams, B.; Bompoint, S.; De Galan, B. E.; Joshi, R.; Travert, F. (2008-06-12). "Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes" (PDF). New England Journal of Medicine. 358 (24). 2560–2572.

. Anderson, Sharon; Brenner, Barry M. (1988). Pathogenesis of Diabetic Glomerulopathy. The Role of Glomerular Hyperfiltration. Springer US, pp. 139–146.

. Atkinson M. A. and Eisenbarth G. S. Type 1 diabetes: new Prospective on disease pathogenesis and treatment. Lancet, 2001; 358 (9277): 221–29.

. Bianchi, Stefano; Bigazzi, Roberto; Caiazza, Alberto; Campese, Vito M. (2003-03-01). "A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease". American Journal of Kidney Diseases. 41 (3): 565–570.

. Brenner, Barry M.; Cooper, Mark E.; de Zeeuw, Dick; Keane, William F.; Mitch, William E.; Parving, Hans-Henrik; Remuzzi, Giuseppe; Snapinn, Steven M.; Zhang, Zhonxin; Shahinfar, Shahnaz (2001-09-20). "Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy". New England Journal of Medicine. 345 (12): 861–869.

. CDC–Chronic Kidney Disease – Glossary". Retrieved 2015-07-02.

. DCCT/EDIC Research Group; de Boer, Ian H.; Sun, Wanjie; Cleary, Patricia A.; Lachin, John M.; Molitch, Mark E.; Steffes, Michael W.; Zinman, Bernard (2011-12-22). "Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes". The New England Journal of Medicine. 365 (25): 2366–2376.

. de Boer IH (August 2017). "A New Chapter for Diabetic Kidney Disease". The New England Journal of Medicine. 377 (9): 885–887.

. diabetic nephropathy". Retrieved 2015-06-27.5– Schlöndorff D, Banas B (June 2009). "The mesangial cell revisited: no cell is an island". Journal of the American Society of Nephrology. 20: 1179–87.

. Ding Y, Choi ME (January 2015). "Autophagy in diabetic nephropathy". The Journal of Endocrinology. 224 (1): R15–30.

. Duckworth, W.; Abraira, C.; Moritz, T. (April 2009). "Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes". Journal of Vascular Surgery. 49 (4): 1084.

. Freedman, Barry I.; Bostrom, Meredith; Daeihagh, Pirouz; Bowden, Donald W. (2007-10-17). "Genetic Factors in Diabetic Nephropathy". Clinical Journal of the American Society of Nephrology. 2 (6): 1306–1316.

. Fried, Linda F.; Emanuele, Nicholas; Zhang, Jane H.; Brophy, Mary; Conner, Todd A.; Duckworth, William; Leehey, David J.; McCullough, Peter A.; O'Connor, Theresa; Palevsky, Paul M.; Reilly, Robert F. (2013-11-14). "Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy". New England Journal of Medicine. 369 (20): 1892–1903.

. Glodny B, Unterholzner V, Taferner B, et al. (2009). "Normal kidney size and its influencing factors – a 64-slice MDCT study of 1,040 asymptomatic patients". BMC Urology. 9 (1): 19.

. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (January 2005). "Diabetic nephropathy: diagnosis, prevention, and treatment". Diabetes Care. 28 (1): 164–76.

. Hall J, Guyton A (2005). Textbook of Medical Physiology (11th ed.). Philadelphia: W.B. Saunders. p. 310.

. Hannedouche, T.; Delgado, A. G.; Gnionsahe, D.; Boitard, C.; Grünfeld, J. P. (2009). "Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes". Kidney International. 35 (4): 898–905.

. Henrich, William L.; Maquire, J. A.; Miller, T. R.; Dover, E. D. (1999-05-10). "The effects of dietary protein restriction on the progression of diabetic nephropathy". American Journal of Kidney Diseases. 18 (4): 330–337.

. Hodgin, Jeffrey B.; Bitzer, Markus; Wiggins, Roderick C.; Sligar, Adrian; Wickman, Leslie; Afshinnia, Farhad; Kretzler, Matthias (2015-01-29). "Glomerular aging and focal global glomerulosclerosis: a podometric perspective". Journal of the American Society of Nephrology. 26 (12): 3162–3178.

. Hricik, Donald E.; Browning, Patrick J.; Kopelman, Raymond; Bryan, Fred A.; Madias, Nicolaos E. (1999-10-22). "Captopril-induced functional renal insufficiency in patients with bilateral renal artery stenoses or renal artery stenosis in a solitary kidney". New England Journal of Medicine. 308 (7): 373–376.

. Lewis, E. J.; Hunsicker, L. G.; Bain, R. P.; Rohde, R. D. (2001-11-12). "The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy". New England Journal of Medicine. 329 (20): 1456–1462.

. Schrier, R. W.; Estacio, R. O.; Esler, A.; Mehler, P. (2002-02-25). "Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes". New England Journal of Medicine. 345 (12): 861–869.

. Hannedouche, T.; Delgado, A. G.; Gnionsahe, D.; Boitard, C.; Grünfeld, J. P. (2009). "Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes". Kidney International. 35 (4): 898–905.

. Henrich, William L.; Maquire, J. A.; Miller, T. R.; Dover, E. D. (1999-05-10). "The effects of dietary protein restriction on the progression of diabetic nephropathy". American Journal of Kidney Diseases. 18 (4): 330–337.

. Hodgin, Jeffrey B.; Bitzer, Markus; Wiggins, Roderick C.; Sligar, Adrian; Wickman, Leslie; Afshinnia, Farhad; Kretzler, Matthias (2015-01-29). "Glomerular aging and focal global glomerulosclerosis: a podometric perspective". Journal of the American Society of Nephrology. 26 (12): 3162–3178.

. Hricik, Donald E.; Browning, Patrick J.; Kopelman, Raymond; Bryan, Fred A.; Madias, Nicolaos E. (1999-10-22). "Captopril-induced functional renal insufficiency in patients with bilateral renal artery stenoses or renal artery stenosis in a solitary kidney". New England Journal of Medicine. 308 (7): 373–376.

. Lewis, E. J.; Hunsicker, L. G.; Bain, R. P.; Rohde, R. D. (2001-11-12). "The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy". New England Journal of Medicine. 329 (20): 1456–1462.

. Schrier, R. W.; Estacio, R. O.; Esler, A.; Mehler, P. (2002-02-25). "Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes". New England Journal of Medicine. 345 (12): 861–869.

. Townsend, Raymond (2009-01-07). Faculty Opinions recommendation of Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

. Umanath, Kausik; Lewis, Julia B. (2018-06-01). "Update on Diabetic Nephropathy: Core Curriculum 2018". American Journal of Kidney Diseases. 71 (6): 884–895.

. Walter F Boron (2004).

. Wolffenbuttel, B. H. R.; Boulanger, C. M.; Crijns, F. R. L.; Huijberts, M. S. P.; Poitevin, P.; Swennen, G. N. M.; Vasan, S.; Egan, J. J.; Ulrich, P.; Cerami, A.; Levy, B. I. (1998-04-14). "Breakers of advanced glycation end products restore large artery properties in experimental diabetes". Proceedings of the National Academy of Sciences. 95 (8): 4630–4634.

. World Health Organization (WHO). Statistics by country for type 2 Diabetes, 2006.

. Yan, Shi-Fang; Ramasamy, Ravichandran; Bucciarelli, Loredana G.; Wendt, Thoralf; Lee, Larisse K.; Hudson, Barry I.; Stern, David M.; Lalla, Evanthia; Du Yan, Shi; Rong, Ling Ling; Naka, Yoshifumi (May 2004). "RAGE and its ligands: a lasting memory in diabetic complications?". Diabetes and Vascular Disease Research. 1 (1): 10–20.